Hypothesis

Receiving bright light (≥5000 lux) within 5 minutes of waking, rather than the conventional 30‑minute window, produces a larger and more sustained increase in locus coeruleus norepinephrine (NE) release. This amplified NE tone persists into the ensuing sleep period, boosting glymphatic CSF‑interstitial fluid exchange and increasing clearance of metabolic waste such as amyloid‑β. Consequently, early light exposure will yield greater reductions in overnight amyloid‑β burden and higher sleep spindle density than standard timing, independent of total light dose.

Mechanistic Rationale

Melanopsin‑expressing ipRGCs drive two parallel pathways: (1) glutamatergic/PACAP signaling to the SCN for circadian phase adjustment [1]; (2) collateral projections to the peri‑locus coeruleus region that stimulate NE neurons. Light‑induced NE elevation enhances arousal and cortical plasticity during wakefulness, but NE also regulates vascular tone and astrocytic aquaporin‑4 polarization, key determinants of glymphatic inflow [2]. We propose that the NE surge triggered by light decays with a half‑life of ~90 min; therefore, light delivered sooner after waking aligns the peak NE concentration with the early sleep onset window, when glymphatic activity is highest. This temporal coupling maximizes waste clearance without altering total photon energy.

Predictions

1. Participants receiving 5‑minute light will show a significantly larger increase in salivary NE metabolites (e.g., MHPG) at 15 min post‑exposure compared with the 30‑minute group.
2. Overnight EEG will reveal higher spindle density (12‑15 Hz) and greater slow‑wave slope in the early‑light condition.
3. Morning CSF amyloid‑β levels (measured via lumbar puncture or PET tracer displacement) will be lower after early light, even when total lux‑minutes are equated.
4. Subjective sleep quality and psychomotor vigilance will improve more in the early‑light group, correlating with NE and spindle metrics.

Experimental Design

A within‑subject, counterbalanced crossover study with healthy adults (n = 30). Each participant completes two nocturnal sessions separated by ≥1 week: (A) 5‑minute light at 0‑5 min after wake; (B) 30‑minute light at 25‑55 min after wake. Light intensity and spectrum (broadband white, 6500 K) are identical. Saliva for NE metabolites is collected at 0, 15, 30 min post‑light. Overnight polysomnography records EEG, EMG, EOG. CSF amyloid‑β is sampled via lumbar puncture at 02:00 h and 06:00 h. Primary outcome: difference in amyloid‑β clearance rate between conditions.

Potential Confounds & Controls

• Circadian phase: both sessions occur at the same clock time; melatonin assays verify equivalent baseline phases.
• Sleep inertia: participants remain in dim red light (<10 lux) until light onset to avoid confounding visual cues.
• Activity level: participants stay seated, avoiding exercise‑induced NE spikes.
• Individual NE baseline: genotype for ADRA2A polymorphisms is recorded as a covariate.

If early light fails to produce greater NE elevation, spindle enhancement, or amyloid‑β clearance relative to the later‑light condition, the hypothesis is falsified. Conversely, confirmation would suggest a novel, non‑circadian mechanism by which morning light optimizes brain waste management, opening avenues for personalized light‑timing protocols in neurodegenerative risk reduction.